19.25
Schlusskurs vom Vortag:
$19.34
Offen:
$19.45
24-Stunden-Volumen:
6.16M
Relative Volume:
1.08
Marktkapitalisierung:
$13.27B
Einnahmen:
$2.87B
Nettoeinkommen (Verlust:
$250.10M
KGV:
60.38
EPS:
0.3188
Netto-Cashflow:
$1.13B
1W Leistung:
+1.42%
1M Leistung:
-6.01%
6M Leistung:
+17.31%
1J Leistung:
+3.83%
Healthpeak Properties Inc Stock (DOC) Company Profile
Firmenname
Healthpeak Properties Inc
Sektor
Telefon
949-407-0700
Adresse
4600 SOUTH SYRACUSE STREET, DENVER, WI
Compare DOC vs WELL, VTR, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DOC
Healthpeak Properties Inc
|
19.25 | 13.27B | 2.87B | 250.10M | 1.13B | 0.3188 |
|
WELL
Welltower Inc
|
237.32 | 171.01B | 11.75B | 1.46B | 2.19B | -0.6014 |
|
VTR
Ventas Inc
|
86.80 | 44.52B | 6.13B | 272.21M | 1.38B | 0.5521 |
|
OHI
Omega Healthcare Investors Inc
|
46.23 | 14.01B | 1.24B | 655.98M | 857.80M | 2.063 |
|
AHR
American Healthcare Reit Inc
|
53.02 | 11.56B | 2.37B | 101.67M | 169.19M | 0.5775 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-07 | Eingeleitet | Barclays | Equal Weight |
| 2026-06-17 | Fortgesetzt | Raymond James | Mkt Perform |
| 2026-06-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2026-05-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-04-20 | Eingeleitet | UBS | Neutral |
| 2026-02-05 | Herabstufung | Argus | Buy → Hold |
| 2026-01-09 | Eingeleitet | Goldman | Neutral |
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-09-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-08-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-07-29 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-01-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-10-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-05-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-04-26 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-04-22 | Fortgesetzt | Mizuho | Buy |
| 2024-04-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-03-25 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-03-08 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2024-01-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-05 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-19 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-04-26 | Eingeleitet | Barclays | Overweight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-07 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2021-09-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-20 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-03-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2020-12-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-30 | Fortgesetzt | Robert W. Baird | Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Buy |
| 2020-04-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-01 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-03-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-02-27 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2019-12-20 | Eingeleitet | Mizuho | Buy |
| 2019-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-26 | Hochstufung | Stifel | Hold → Buy |
| 2019-10-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-06-20 | Eingeleitet | Citigroup | Neutral |
| 2019-05-02 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2018-08-03 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2018-04-25 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-01-05 | Bestätigt | Robert W. Baird | Outperform |
| 2017-11-06 | Hochstufung | Hilliard Lyons | Long-term Buy → Buy |
Alle ansehen
Healthpeak Properties Inc Aktie (DOC) Neueste Nachrichten
Wells Fargo Maintains Healthpeak Properties(DOC.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Healthpeak Properties, Inc. (DOC) Stock Forecasts - Yahoo Finance
Healthpeak Properties Inc (DOC) Shares Fall 3.1% -- What GF Scor - GuruFocus
Healthpeak Properties Inc. stock underperforms Monday when compared to competitors - MarketWatch
DOC Maintained by Wells Fargo -- Price Target Lowered to $19.00 - GuruFocus
Is Healthpeak Properties (NYSE:DOC) Undervalued After Its Pullback? - Kalkine Media
Wells Fargo Adjusts Healthpeak Properties Price Target to $19 From $22 - marketscreener.com
Healthpeak Properties Inc's Dividend Analysis - Yahoo Finance
Healthpeak Properties (NYSE:DOC)Stock Analysis - Simply Wall Street
Healthpeak Properties Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
What Does Healthpeak Properties' Second-Quarter Update Show About This S&P 500 Stock (NYSE:DOC)? - Kalkine Media
Healthpeak Properties, Inc.: Performance & Quotes, HC5 Stock Price on Tradegate Exchange - www.marketscreener.com
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
Better High-Yield Dividend Stock: Realty Income vs. Healthpeak - Yahoo Finance
Healthpeak Properties Is Maintained at Neutral by UBS - Moomoo
Should Raised Guidance Require Action From Healthpeak Properties (DOC) Investors? - Simply Wall Street
Healthpeak Properties (DOC) Reaffirmed Its Dividend, Is It Still Below Fair Value? - Yahoo Finance
Healthpeak Properties (DOC) Stock Still Looks Cheap Following Its 31% Run - Yahoo Finance
Healthpeak Properties: High Yield, Strong Balance Sheet, Upside Potential (NYSE:DOC) - Seeking Alpha
Jefferies Adjusts Price Target on Healthpeak Properties to $19 From $21 - www.marketscreener.com
Healthpeak Properties Inc. stock outperforms competitors on strong trading day - MarketWatch
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises - Zacks Investment Research
PEAK4909399 Bond Profile: Coupon and Redemption - TradingView
Why Investors Need to Take Advantage of These 2 Finance Stocks Now - Zacks Investment Research
Healthpeak Properties Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Healthpeak Properties: Can This Healthcare REIT Keep Funding Its Dividend - Yahoo Finance
A Look at Healthpeak Properties Inc (DOC) After 3.3% Decline -- GF Value $20.28 vs Price $18.84 - GuruFocus
Healthpeak Properties Inc. stock underperforms Monday when compared to competitors - MarketWatch
Healthpeak Properties’ Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Healthpeak Properties’ Quarterly Earnings Preview: What You Need to Know - Barchart.com
Healthpeak Properties (DOC) Maintains Monthly Dividend with 6.28% Yield Amid Updated 2026 FFO Guidance - GuruFocus
Healthpeak Properties Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Healthpeak Properties Announces Dates of Third Quarter 2026 Earnings Release, Conference Call, and Webcast - Business Wire
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
PEAK4849214 Bond Profile: Coupon and Redemption - TradingView
Healthpeak Properties, Inc. Common Stock (NY: DOC - The Chronicle-Journal
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
How Investors May Respond To Healthpeak Properties (DOC) Upgrading Its 2026 Cash-Flow Guidance - Yahoo Finance
Is Healthpeak Properties Stock Underperforming the S&P 500? - Yahoo Finance
Alexandria Real Estate: It Bounced Off Support And Is Now At Resistance (NYSE:ARE) - Seeking Alpha
Healthpeak Properties Inc. stock outperforms competitors on strong trading day - MarketWatch
Looking for Steady Passive Income? This S&P 500 Dividend Stock Pays You Monthly. - The Motley Fool
Healthpeak Properties: Buy Reaffirmed As Outpatient And Senior Portfolio Shows Proven Performance - Seeking Alpha
Healthpeak Properties Inc's Dividend Analysis - Yahoo Finance
Healthpeak Properties Inc. stock underperforms Friday when compared to competitors - MarketWatch
Why Is Healthpeak (DOC) Down 3.5% Since Last Earnings Report? - finance.yahoo.com
Healthpeak Properties Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Healthpeak Properties, Inc. (NYSE: DOC) President and CEO Scott Brinker Interviewed by Advisor Access - The Manila Times
Healthpeak Properties, Inc. (NYSE: DOC) President and CEO Scott Brinker Interviewed by Advisor Access - marketscreener.com
Finanzdaten der Healthpeak Properties Inc-Aktie (DOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Healthpeak Properties Inc-Aktie (DOC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bohn Scott R | Officer |
May 12 '26 |
Proposed Sale |
19.45 |
10,989 |
213,741 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):